All Stories

  1. Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2
  2. Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients over 75 years of age
  3. Anti-inflammatory effects of a novel NF-kB inhibitory derivative derived from pyrazolo[3,4-d]pyrimidine in three inflammation models
  4. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching
  5. Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity
  6. Abdominal obesity increases the risk of death in COVID-19
  7. Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
  8. A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia
  9. Mass-like Lesions Causing Compression of Large Vessels in Granulomatosis with Polyangiitis: A Case Report
  10. Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
  11. Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity
  12. An adult case of suspected A20 haploinsufficiency mimicking polyarteritis nodosa
  13. Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease
  14. Therapeutic Effect of Cyclin‐Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis
  15. CD34+THY1+ synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro
  16. Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity
  17. Plasma Levels of Decorin Increased in Patients during the Progression of Breast Cancer
  18. Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts
  19. Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan
  20. Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge
  21. Editorial: Targeting the Chemoattractant System in Inflammation
  22. Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study
  23. Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like Synoviocytes
  24. Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy
  25. Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist
  26. Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine Adjuvants
  27. Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC)
  28. Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
  29. Successful use of rituximab in a patient with refractory thrombotic thrombocytopaenic purpura complicated by polymyositis
  30. Acquired Gitelman Syndrome in an Anti-SSA Antibody-positive Patient with a <i>SLC12A3</i> Heterozygous Mutation
  31. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without <i>TNFRSF1A</i> Mutations Successfully Treated with Tocilizumab
  32. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE)
  33. Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression
  34. Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections
  35. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis